Michael Link
Clinical Trials
- Not Recruiting School Response to Families Who Have Children With Cancer
- Not Recruiting Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
- Not Recruiting A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma
- Not Recruiting Therapy for Pediatric Hodgkin Lymphoma
- Not Recruiting Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment
- Not Recruiting A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
- Recruiting Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma

